Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

Not yet recruiting 120 enrolled College of Physicians and Surgeons Pakistan

NaSingle-groupOpen-labelPrevention

Summary

To assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD.

Timeline

Start: 2026-01-01
Primary completion: 2026-06-30
Completion: 2026-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Finerenone	Small molecule	—	—

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

Summary

Timeline

Drugs

Indications